Overview of the Lao version of generic ivonib usage guidelines

The Lao version of ivosidenib generic drug (English generic name: ivosidenib), as an affordable treatment option for IDH1 mutated cancer, brings new treatment hope to patients. The following is a brief introduction to this version of the Guidelines for the Use of Generic Medications, designed to help patients better understand and use this medicine.

1. Basic information about drugs

The Lao version of Ivonib generic drug is a generic version of the original drug. Its active ingredients are the same as the original drug, but the production cost is lower, so the price is more affordable. The drug is mainly suitable for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (R/R AML) who carry IDH1 mutations, as well as patients with previously treated locally advanced or metastatic cholangiocarcinoma. In addition, it can be used as monotherapy or in combination with azacitidine to treat patients with newly diagnosed AML under certain conditions, as well as patients with relapsed or refractory myelodysplastic syndrome (MDS).

2. Medication guidance

The recommended dose is 500 mg per time taken orally once daily and continued until disease progression or intolerable toxicity occurs. Patients can choose to take it on an empty stomach or after meals, but should avoid taking it with high-fat foods at the same time to avoid affecting the drug absorption effect. It is recommended to take the medicine at a fixed time every day to maintain a stable blood concentration. If you vomit after taking the medicine, there is no need to take another dose, just wait for the next scheduled dose. If you miss the medication time, you should take it as soon as possible, but the interval between two doses should not be less than 12 hours.

3. Precautions for use

1. Before using ivonib, patients must be confirmed to carry the IDH1 mutation by a confirmatory testing method.

2. During treatment, blood cell counts, blood biochemical indicators and electrocardiograms should be monitored regularly to detect and deal with possible adverse reactions in a timely manner.

3. Avosidenib may interact with other drugs, especially strongCYP3A4 inhibitors. If combined medication is needed, please adjust the dosage under the guidance of a doctor.

4. Patients with liver and kidney dysfunction should use it with caution under the guidance of a doctor, and adjust the dosage according to the specific situation.

5. Patients of childbearing potential should use appropriate contraceptive measures while using ivonib to avoid potential risks. If you become pregnant unexpectedly during treatment or suspect that you may be pregnant, please inform your doctor immediately.

4. Possible adverse reactions

Ivonib may cause a series of adverse reactions, including but not limited to fatigue, joint pain, leukocytosis, diarrhea, nausea, etc. Patients should pay close attention to their physical reactions during use and communicate with their doctor in time if they experience any discomfort.

5. Specifications and Prices

The generic version of Ivonib produced by Laos Lucius Pharmaceutical Company is 250mg*60 tablets/box, and the price of each box is about more than 6,000 yuan, which reduces the financial burden for patients. When purchasing medicines, be sure to choose formal and guaranteed channels to ensure the formality and reliability of the source of the medicines.

In summary, the Lao version of the generic version of ivonib provides patients with an affordable treatment option. However, when using this drug, patients still need to strictly abide by the doctor's instructions and pay attention to usage, dosage and possible adverse reactions to ensure the safety and effectiveness of the treatment.